Lindbrook Capital LLC boosted its position in shares of Teladoc Health, Inc. (NYSE:TDOC – Free Report) by 78.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,654 shares of the health services provider’s stock after acquiring an additional 1,612 shares during the quarter. Lindbrook Capital LLC’s holdings in Teladoc Health were worth $33,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Connor Clark & Lunn Investment Management Ltd. raised its position in Teladoc Health by 15.5% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider’s stock worth $15,617,000 after acquiring an additional 228,004 shares in the last quarter. Jennison Associates LLC bought a new stake in Teladoc Health during the third quarter worth $1,544,000. Massachusetts Financial Services Co. MA raised its position in Teladoc Health by 477.1% during the third quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider’s stock worth $3,397,000 after acquiring an additional 305,961 shares in the last quarter. Geode Capital Management LLC raised its position in Teladoc Health by 1.5% during the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock worth $36,042,000 after acquiring an additional 56,864 shares in the last quarter. Finally, Maple Rock Capital Partners Inc. bought a new stake in Teladoc Health during the third quarter worth $11,291,000. 76.82% of the stock is owned by institutional investors.
Teladoc Health Trading Down 2.5 %
TDOC stock opened at $9.16 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The company’s 50-day simple moving average is $10.62 and its 200 day simple moving average is $9.65. Teladoc Health, Inc. has a 52 week low of $6.76 and a 52 week high of $15.95. The company has a market capitalization of $1.59 billion, a PE ratio of -1.59 and a beta of 1.27.
Wall Street Analyst Weigh In
Several analysts have issued reports on TDOC shares. Royal Bank of Canada upped their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. The Goldman Sachs Group decreased their price objective on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a report on Monday, March 3rd. Piper Sandler decreased their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a report on Thursday, February 27th. Finally, Oppenheimer decreased their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, Teladoc Health has an average rating of “Hold” and a consensus target price of $11.26.
Check Out Our Latest Report on TDOC
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
See Also
- Five stocks we like better than Teladoc Health
- How to Short Nasdaq: An Easy-to-Follow Guide
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- What is the Euro STOXX 50 Index?
- 3 Stocks to Buy While Others Stay on the Sidelines
- Transportation Stocks Investing
- MarketBeat Week in Review – 03/03 – 03/07
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Free Report).
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.